Project Grant K23AI196262
Award Date 5/22/26
Completion Date 4/30/31
Dollars Obligated $264K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $427,625 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, effective February 4, 2026, with completion targeted for January 31, 2028, supports investigator-initiated research examining the role of calcineurin phosphatase in regulating CD8+ T cell immunity. The research project delivers mechanistic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $427,625 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025, through July 31, 2027. The grant supports research to identify and develop novel anti-biofilm therapeutic agents by exploiting bacteriophage mechanisms that penetrate bacterial biofilm matrices. The research focuses on mining...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $715,894 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, for a five-year research initiative extending through July 31, 2030. This award funds fundamental biomedical research investigating the influence of microbial metabolites on mitosome function in Cryptosporidium parvum, a parasitic pathogen...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $777,360 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This award funds research titled "Advancing Lymphatic Filariasis Elimination with Parasite Genomic Epidemiology," which will deliver comprehensive genomic analysis and characterization of Wuchereria bancrofti...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $596,115 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, with completion targeted for July 31, 2030. This five-year award supports investigator-initiated biomedical research examining the long-term impact of persistent parainfluenza virus infection, specifically focusing on how human...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $638,220 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate DNA ADP-ribosylation mechanisms in bacterial-phage interactions. The five-year research project, initiated April 1, 2026 and concluding March 31, 2031, will generate scientific knowledge regarding how bacteria utilize DNA-targeting ADP-ribosyltransferase...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $427,626 Project Grant (CFDA 93.855, Allergy and Infectious Diseases Research) effective April 1, 2026 through March 31, 2028. The award supports investigator-initiated biomedical research to identify host factors that mediate the nuclear retention of unspliced and partially spliced human immunodeficiency virus type 1 (HIV-1) transcripts. The research...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $233,250 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2027. This award funds research to optimize culturomic and metagenomic methods for detecting multi-strain Clostridioides difficile (CD) colonization and infection. The project addresses a critical gap in current...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $664,076 Project Grant effective April 1, 2026, through March 31, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award supports investigator-initiated biomedical research examining the molecular mechanisms by which Staphylococcus aureus alpha-toxin (HLA) impairs antigen-specific T cell responses and adaptive immunity....
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $233,250.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period June 1, 2026 through May 31, 2028. This project focuses on elucidating the mechanisms and identifying therapeutic targets for a novel inborn error of immunity caused by gain-of-function variants in Toll-Like Receptor 8 (TLR8). The research...